These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5568050)

  • 1. Additional evidence for the existence of a precursor molecule of the prothrombin complex in oral anticoagulation.
    Veltkamp JJ; Muis H; Muller AD; Hemker HC; Loeliger EA
    Thromb Diath Haemorrh; 1971 Jun; 25(2):312-5. PubMed ID: 5568050
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
    Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
    Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of Yoshida sarcoma, -aminocaproic acid and sintrom on the blood clotting system in rats.
    Kotschy M; Grzebieluch M; Szacki J; Lawiñski M
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):515-22. PubMed ID: 5095070
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacology of oral anticoagulants].
    Richter M; Markwardt F
    Z Gesamte Inn Med; 1979 Jan; 34(1):8-17. PubMed ID: 433362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experiences with chromatographic DEAE adsorbed prothrombin complex for control of bleeding and multiple tooth extraction in hemophilia B patients.
    Onishi H; Izuchi K; Matsumoto T; Kato R; Kusunose K
    Nihon Ketsueki Gakkai Zasshi; 1971 Aug; 34(4):513-6. PubMed ID: 5317288
    [No Abstract]   [Full Text] [Related]  

  • 6. The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy.
    Bourgain RH; Vanden Driessche R; Smets P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):240-6. PubMed ID: 5015934
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of action of oral anticoagulants].
    Uszyński L
    Acta Haematol Pol; 1972; 3(2):133-9. PubMed ID: 4655612
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the prothrombin complex, II. Behavior of prothrombin, factor VII, IX and X during column chromatography on anion exchangesRS].
    Voss D
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1172-8. PubMed ID: 5588277
    [No Abstract]   [Full Text] [Related]  

  • 9. Prothrombin concentrates in treatment of Christmas disease and allied disorders.
    Breen FA; Tullis JL
    JAMA; 1969 Jun; 208(10):1848-52. PubMed ID: 5818828
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of clotting inhibitive chronic dose of phenprocoumon on the prothrombin level and various enzymes of the rat].
    Stresemann E; Ast D
    Arzneimittelforschung; 1971 Jan; 21(1):145. PubMed ID: 5108379
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of drugs on the treatment with oral anticoagulants].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1973 Sep; 117(37):1396-9. PubMed ID: 4787075
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulation activation and reactive fibrinolysis in patients receiving oral anticoagulation after total hip or knee replacement.
    van Wersch JW; de Vries-Hanje JC; Oosterbos C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):605-8. PubMed ID: 7841318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy.
    Pfäfflin A
    Clin Chem Lab Med; 2009; 47(2):242-3. PubMed ID: 19191733
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune reactive factor IX in acquired factor IX deficiency.
    Lechner K
    Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of calcium chloride on blood coagulation].
    Novak EN; Iadrova VM
    Farmakol Toksikol; 1967; 30(2):192-5. PubMed ID: 5599523
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in the control of oral anticoagulation.
    Loeliger EA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):109-19. PubMed ID: 5074987
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous and oral sulodexide versus coagulation activation markers in humans.
    Borawski J; Dubowski M; Rydzewska-Rosolowska A; Mysliwiec M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):596-8. PubMed ID: 19910295
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of prothrombin activating snake venoms to measure human prethrombin 2: absence of prethrombin 2 in serum.
    Aronson DL; Franza BR; Bagley J
    Thromb Res; 1984 Jun; 34(5):419-29. PubMed ID: 6377573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.